Epidemics: The Story of South Africa’s Five Most Lethal Human Diseases (Ohio Short Histories of Africa)
Description:
This is the first history of epidemics in South Africa, lethal episodes that significantly shaped this society over three centuries. Focusing on five devastating diseases between 1713 and today—smallpox, bubonic plague, “Spanish influenza,” polio, and HIV/AIDS—the book probes their origins, their catastrophic courses, and their consequences in both the short and long terms. The impacts of these epidemics ranged from the demographic—the “Spanish flu,” for instance, claimed the lives of 6 percent of the country’s population in six weeks—to the political, the social, the economic, the spiritual, the psychological, and the cultural. Moreover, as each of these epidemics occurred at crucial moments in the country’s history—such as during the South African War and World War I—the book also examines how these processes affected and were affected by the five epidemics. To those who read this book, history will not look the same again.
Best prices to buy, sell, or rent ISBN 9780821420287
Frequently Asked Questions about Epidemics: The Story of South Africa’s Five Most Lethal Human Diseases (Ohio Short Histories of Africa)
The price for the book starts from $6.13 on Amazon and is available from 26 sellers at the moment.
If you’re interested in selling back the Epidemics: The Story of South Africa’s Five Most Lethal Human Diseases (Ohio Short Histories of Africa) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Epidemics: The Story of South Africa’s Five Most Lethal Human Diseases (Ohio Short Histories of Africa) book, the best buyback offer comes from and is $ for the book in good condition.
The Epidemics: The Story of South Africa’s Five Most Lethal Human Diseases (Ohio Short Histories of Africa) book is in very low demand now as the rank for the book is 753,831 at the moment. It's a very low rank, and the book has minimal sales on Amazon.
Not enough insights yet.